Publications

The CNODES network of researchers, trainees, and analysts conduct studies using administrative healthcare data in response to queries from Canadian regulators. The results of these studies are published in open-access academic journals. CNODES also publishes a selection of its methodological advances, knowledge translation initiatives, and trainee projects.

Ukah UV, Aibibula W, Platt RW, Dayan N, Reynier P, Filion KB. Time-related biases in perinatal pharmacoepidemiology: A systematic review of observational studies. Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1228-1241.

Brunetti VC, St-Jean A, Dell’Aniello S, Fisher A, Yu OHY, Bugden SC, Daigle JM, Hu N, Alessi-Severini S, Shah BR, Ronksley PE, Lix LM, Ernst P, Filion KB; for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom. BMC Endocr Disord. 2022 Sep 29;22(1):241.

Masarwa R, Lefebvre C, Platt RW, Filion KB. General practitioner prescribing trends among pediatric patients in the United Kingdom: 1998-2018. Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):302-313.

Su CL, Platt RW, Plante JF. Causal inference for recurrent event data using pseudo-observations. Biostatistics. 2022 Jan 13;23(1):189-206.

Sinyavskaya L, Renoux C, Durand M. Defining the duration of the dispensation of oral anticoagulants in administrative healthcare databases. Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):105-109.

Sketris IS, Traynor RL, Helwig M, Burland E, Stewart SA. Exploring female parity in pharmacoepidemiology authorship: A case study of the Canadian Network for Observational Drug Effect Studies and its citing articles. Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):82-90.

Nakhlé G, Brophy JM, Renoux C, Khairy P, Bélisle P, LeLorier J. Domperidone increases harmful cardiac events in Parkinson’s Disease: A Bayesian re-analysis of an observational study. J Clin Epidemiol. 2021 Dec;140:93-100.

Sinyavskaya L, Schnitzer M, Renoux C, Guertin JR, Talbot D, Durand M. Evidence of the different associations of prognostic factors with censoring across treatment groups and impact on censoring weight model specification: the example of anticoagulation in atrial fibrillation. Am J Epidemiol. 2021 Dec 1;190(12):2671-2679.

Dormuth CR, Fisher A, Hudson M, Austin PC, Ernst P, Bresee L, Chateau D, Tamim H, Paterson JM, Lafrance JP, Taylor-Gjevre RM, Platt RW, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Impact of concomitant conventional DMARD on persistence of biologic DMARDS in rheumatoid arthritis: multi-centre, population-based cohort study. Semin Arthritis Rheum. 2021 Dec;51(6):1291-1299.

Ou LB; Moriello C; Douros A; Filion KB. Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2021 Oct;87(10):3649-3658.